Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Neoplasms Clinical Trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7301) clinical trials

Heavy periods associated with uterine fibroids? You may want to consider participating in a clinical research study. The My Fibroid Study (MyUFStudy.com) is evaluating an investigational study drug to see if it may safely and effectively reduce bleeding during your period.

Phase N/A

People with T- and NK-cell Neoplasms are asked to participate in a research study being conducted by Northwell Health.

Phase N/A

If you have uterine fibroids that are causing heavy monthly bleeding, you may be eligible to participate in our medical research study.

Phase

If you have been living with heavy periods due to uterine fibroids, participating in a research study may be an option. The Asteroid Studies are research studies evaluating the safety and effectiveness of an investigational oral medication for uterine fibroids.

Phase N/A

People with pancreatic cancer are asked to participate in a research study being conducted by Northwell Health.  

Phase N/A

The purpose of this research study is to determine if pelvic floor therapy is effective in treating pain related sexual dysfunction. We are interested in examining pelvic floor therapy (a type of gynecologic physical therapy) as an intervention for sexual dysfunction.

Phase N/A

This is phase 3b study seeks to evaluate the safety and efficacy of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. This study is double-blinded in the first year and an open-label in the second year.

Phase

The purpose of this study is to determine the benefit and safety of relugolix 40 mg once daily co-administered with low dose estradiol and norethindrone acetate compared with placebo for 24 weeks on heavy menstrual bleeding associated with uterine fibroids. Additionally, this study is designed to evaluate the benefit of ...

Phase

This is a clinical trial aimed to determine the best tolerated dosage of Cetuximab into arteries for the treatement of un-resectable recurrent head and neck cancer. Cetuximab belongs in a class of drugs called epidermal growth factor receptor (EGFR) inhibitors. A high percentage of head and neck cancers over-express EGFR. ...

Phase